Serologic Markers in the Diagnosis and Management of IBD.
作者信息
Vermeire Severine
机构信息
Assistant Professor of Medicine Department of Internal Medicine Katholieke Universiteit Leuven Leuven, Belgium.
出版信息
Gastroenterol Hepatol (N Y). 2007 Jun;3(6):424-6.
Abstract
摘要
相似文献
1
Serologic Markers in the Diagnosis and Management of IBD.炎症性肠病诊断与管理中的血清学标志物
Gastroenterol Hepatol (N Y). 2007 Jun;3(6):424-6.
2
Serologic markers in inflammatory bowel disease (IBD).炎症性肠病（IBD）中的血清学标志物。
MLO Med Lab Obs. 2001 Nov;33(11):8-15; quiz 16-9.
3
Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.炎症性肠病的诊断方法：血清学标志物与内镜检查
Surg Clin North Am. 2015 Dec;95(6):1123-41, v. doi: 10.1016/j.suc.2015.07.008. Epub 2015 Oct 21.
4
The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.血清学标志物在炎症性肠病患儿中的诊断准确性：西弗吉尼亚州的经验。
J Clin Gastroenterol. 2005 Sep;39(8):670-3. doi: 10.1097/01.mcg.0000173853.78042.2d.
5
High Incidence of Serologic Markers of Inflammatory Bowel Disease in Asymptomatic Patients with Glycogen Storage Disease Type Ia.Ia型糖原贮积病无症状患者中炎症性肠病血清学标志物的高发生率。
JIMD Rep. 2015;24:123-8. doi: 10.1007/8904_2015_452. Epub 2015 Jun 21.
6
New serologic markers for inflammatory bowel disease diagnosis.炎症性肠病诊断的新型血清学标志物。
Dig Dis. 2010;28(3):418-23. doi: 10.1159/000320396. Epub 2010 Sep 30.
7
The role of autoantibodies in inflammatory bowel disease.自身抗体在炎症性肠病中的作用。
Dig Dis. 2012;30(2):201-7. doi: 10.1159/000336702. Epub 2012 Jun 20.
8
Advances in clinical laboratory tests for inflammatory bowel disease.炎症性肠病临床实验室检测的进展
Clin Chim Acta. 2003 Sep;335(1-2):9-20. doi: 10.1016/s0009-8981(03)00286-9.
9
Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.评价新型血清学标志物和自身抗体在犬炎症性肠病中的作用。
J Vet Intern Med. 2020 May;34(3):1177-1186. doi: 10.1111/jvim.15761. Epub 2020 Apr 13.
10
Relevance of serologic studies in inflammatory bowel disease.血清学研究在炎症性肠病中的相关性。
Curr Gastroenterol Rep. 2004 Dec;6(6):482-7. doi: 10.1007/s11894-004-0070-x.
引用本文的文献
1
Crohn's disease: the first visit.克罗恩病：初诊
Gastroenterol Hepatol (N Y). 2011 Mar;7(3):163-9.
本文引用的文献
1
The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.在一个未经过筛选的基于欧洲人群的炎症性肠病（IBD）患者队列中基因和血清学标志物的患病率。
Inflamm Bowel Dis. 2007 Jan;13(1):24-32. doi: 10.1002/ibd.20047.
2
The value of serologic markers in indeterminate colitis: a prospective follow-up study.血清学标志物在不确定性结肠炎中的价值：一项前瞻性随访研究。
Gastroenterology. 2002 May;122(5):1242-7. doi: 10.1053/gast.2002.32980.
3
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.在一个基于人群的溃疡性结肠炎和克罗恩病患者队列中对血清学疾病标志物进行评估。
Inflamm Bowel Dis. 2001 Aug;7(3):192-201. doi: 10.1097/00054725-200108000-00003.
4
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.血清学诊断检测在疑似儿童炎症性肠病中的临床应用
Am J Gastroenterol. 2001 Mar;96(3):758-65. doi: 10.1111/j.1572-0241.2001.03618.x.
Zotero 插件